Reported Jul 17, 2024 · Announced
Endo USA, Inc recalls Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets due to Mislabeled with the incorrect strength on…
Endo USA, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25
- mg tablets BrandPar Pharmaceutical. Drugs
Why it was recalled
Mislabeled with the incorrect strength on the carton
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Endo USA, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.